A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|6|493-503

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.6, 2015-01, pp. : 493-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: Achievements and challenges

By Lübbert Michael   Kuendgen Andrea  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 498-501

Blackwell Publishing

Access to resources Recommend Favorite

Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 882-893

Bentham Science Publishers

Access to resources Recommend Favorite

Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor

By Gimsing Peter  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 501-508

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic approaches to acute myeloid leukemia

By Uchida Hideo   Inokuchi Koiti   Watanabe Reiko   Tokuhira Michihide   Kizaki Masahiro  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 689-706

Informa Healthcare

Access to resources Recommend Favorite

Perifosine – a new option in treatment of acute myeloid leukemia?

By Krawczyk Janusz   Keane Niamh   Swords Ronan   O'Dwyer Michael   Freeman Ciara L   Giles Francis J  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1315-1327

Informa Healthcare

Access to resources Recommend Favorite